Ceri H. Davies - Publications

Affiliations: 
GlaxoSmithKline, Collegeville, PA, United States 

89/178 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Williams LA, Joshi V, Murphy M, Ferrante J, Werley CA, Brookings T, McManus O, Grosse J, Davies CH, Dempsey GT. Scalable Measurements of Intrinsic Excitability in Human iPS Cell-Derived Excitatory Neurons Using All-Optical Electrophysiology. Neurochemical Research. PMID 30603979 DOI: 10.1007/S11064-018-2694-5  0.317
2017 Serrats J, Cunningham MO, Davies CH. GABAB receptor modulation-to B or not to be B a pro-cognitive medicine? Current Opinion in Pharmacology. PMID 29050820 DOI: 10.1016/J.Coph.2017.09.012  0.485
2013 Carracedo LM, Kjeldsen H, Cunnington L, Jenkins A, Schofield I, Cunningham MO, Davies CH, Traub RD, Whittington MA. A neocortical delta rhythm facilitates reciprocal interlaminar interactions via nested theta rhythms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 10750-61. PMID 23804097 DOI: 10.1523/Jneurosci.0735-13.2013  0.355
2013 Nathan PJ, Watson J, Lund J, Davies CH, Peters G, Dodds CM, Swirski B, Lawrence P, Bentley GD, O'Neill BV, Robertson J, Watson S, Jones GA, Maruff P, Croft RJ, et al. The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 721-31. PMID 22932339 DOI: 10.1017/S1461145712000752  0.329
2012 Gigout S, Jones GA, Wierschke S, Davies CH, Watson JM, Deisz RA. Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex. Bmc Neuroscience. 13: 42. PMID 22540185 DOI: 10.1186/1471-2202-13-42  0.441
2012 Bashir ZI, Berretta N, Bortolotto ZA, Clark K, Davies CH, Frenguelli BG, Harvey J, Potier B, Collingridge GL. NMDA receptors and long-term potentiation in the hippocampus The Nmda Receptor. DOI: 10.1093/acprof:oso/9780192625021.003.0013  0.803
2011 Nathan PJ, Cobb SR, Lu B, Bullmore ET, Davies CH. Studying synaptic plasticity in the human brain and opportunities for drug discovery. Current Opinion in Pharmacology. 11: 540-8. PMID 21737346 DOI: 10.1016/J.Coph.2011.06.008  0.387
2011 Otton HJ, Lawson McLean A, Pannozzo MA, Davies CH, Wyllie DJ. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs. Neuropharmacology. 60: 388-96. PMID 20955720 DOI: 10.1016/J.Neuropharm.2010.10.008  0.35
2010 Spencer JP, Middleton LJ, Davies CH. Investigation into the efficacy of the acetylcholinesterase inhibitor, donepezil, and novel procognitive agents to induce gamma oscillations in rat hippocampal slices. Neuropharmacology. 59: 437-43. PMID 20600173 DOI: 10.1016/J.Neuropharm.2010.06.005  0.38
2010 Thomas DR, Dada A, Jones GA, Deisz RA, Gigout S, Langmead CJ, Werry TD, Hendry N, Hagan JJ, Davies CH, Watson JM. N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M(1) receptor. Neuropharmacology. 58: 1206-14. PMID 20206188 DOI: 10.1016/J.Neuropharm.2010.02.017  0.302
2010 Dawson LA, Langmead CJ, Dada A, Watson JM, Wu Z, de la Flor R, Jones GA, Cluderay JE, Southam E, Murkitt GS, Hill MD, Jones DN, Davies CH, Hagan JJ, Smith PW. In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics. European Journal of Pharmacology. 627: 106-14. PMID 19879867 DOI: 10.1016/J.Ejphar.2009.10.054  0.417
2010 McLean SL, Harte MK, Marsh S, Jones GA, Davies C, Woolley ML, Neill JC. Time-Dependent Changes in Gamma Oscillations and Parvalbumin Immunoreactive Cell Density in the Ca2/3 Region of the Rat Hippocampus Following Sub-Chronic Phencyclidine Treatment Schizophrenia Research. 117: 486. DOI: 10.1016/J.Schres.2010.02.920  0.352
2009 Dickinson BA, Jo J, Seok H, Son GH, Whitcomb DJ, Davies CH, Sheng M, Collingridge GL, Cho K. A novel mechanism of hippocampal LTD involving muscarinic receptor-triggered interactions between AMPARs, GRIP and liprin-alpha. Molecular Brain. 2: 18. PMID 19534762 DOI: 10.1186/1756-6606-2-18  0.708
2008 Piccinin S, Thuault SJ, Doherty AJ, Brown JT, Randall AD, Davies CH, Bortolotto ZA, Collingridge GL. The induction of long-term plasticity of non-synaptic, synchronized activity by the activation of group I mGluRs. Neuropharmacology. 55: 459-63. PMID 18619627 DOI: 10.1016/J.Neuropharm.2008.05.017  0.795
2008 Langmead CJ, Austin NE, Branch CL, Brown JT, Buchanan KA, Davies CH, Forbes IT, Fry VA, Hagan JJ, Herdon HJ, Jones GA, Jeggo R, Kew JN, Mazzali A, Melarange R, et al. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. British Journal of Pharmacology. 154: 1104-15. PMID 18454168 DOI: 10.1038/Bjp.2008.152  0.722
2008 Salah-Uddin H, Thomas DR, Davies CH, Hagan JJ, Wood MD, Watson JM, Challiss RA. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue. The Journal of Pharmacology and Experimental Therapeutics. 325: 869-74. PMID 18322150 DOI: 10.1124/Jpet.108.137968  0.34
2008 Dawson LA, Cato KJ, Scott C, Watson JM, Wood MD, Foxton R, de la Flor R, Jones GA, Kew JN, Cluderay JE, Southam E, Murkitt GS, Gartlon J, Pemberton DJ, Jones DN, ... Davies CH, et al. In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1642-52. PMID 17728699 DOI: 10.1038/Sj.Npp.1301549  0.42
2007 Driver JE, Racca C, Cunningham MO, Towers SK, Davies CH, Whittington MA, LeBeau FE. Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP). The European Journal of Neuroscience. 26: 1280-8. PMID 17767505 DOI: 10.1111/J.1460-9568.2007.05705.X  0.345
2007 Brown JT, Davies CH, Randall AD. Synaptic activation of GABA(B) receptors regulates neuronal network activity and entrainment. The European Journal of Neuroscience. 25: 2982-90. PMID 17561812 DOI: 10.1111/J.1460-9568.2007.05544.X  0.794
2007 Bibbig A, Middleton S, Racca C, Gillies MJ, Garner H, Lebeau FE, Davies CH, Whittington MA. Beta rhythms (15-20 Hz) generated by nonreciprocal communication in hippocampus. Journal of Neurophysiology. 97: 2812-23. PMID 17287437 DOI: 10.1152/Jn.01105.2006  0.325
2007 McNair K, Broad J, Riedel G, Davies CH, Cobb SR. Global changes in the hippocampal proteome following exposure to an enriched environment. Neuroscience. 145: 413-22. PMID 17261355 DOI: 10.1016/J.Neuroscience.2006.12.033  0.317
2006 Wood MD, Scott C, Clarke K, Westaway J, Davies CH, Reavill C, Hill M, Rourke C, Newson M, Jones DN, Forbes IT, Gribble A. Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. European Journal of Pharmacology. 546: 88-94. PMID 16925992 DOI: 10.1016/J.Ejphar.2006.07.008  0.354
2006 Wood MD, Scott C, Clarke K, Cato KJ, Patel N, Heath J, Worby A, Gordon L, Campbell L, Riley G, Davies CH, Gribble A, Jones DN. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. Cns & Neurological Disorders Drug Targets. 5: 445-52. PMID 16918396 DOI: 10.2174/187152706777950693  0.362
2006 Thomas DR, Soffin EM, Roberts C, Kew JN, de la Flor RM, Dawson LA, Fry VA, Coggon SA, Faedo S, Hayes PD, Corbett DF, Davies CH, Hagan JJ. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. Neuropharmacology. 51: 566-77. PMID 16846620 DOI: 10.1016/J.Neuropharm.2006.04.019  0.358
2006 Widmer H, Ferrigan L, Davies CH, Cobb SR. Evoked slow muscarinic acetylcholinergic synaptic potentials in rat hippocampal interneurons. Hippocampus. 16: 617-28. PMID 16770798 DOI: 10.1002/Hipo.20191  0.493
2006 Cunningham MO, Pervouchine DD, Racca C, Kopell NJ, Davies CH, Jones RS, Traub RD, Whittington MA. Neuronal metabolism governs cortical network response state. Proceedings of the National Academy of Sciences of the United States of America. 103: 5597-601. PMID 16565217 DOI: 10.1073/Pnas.0600604103  0.312
2006 Cunningham MO, Hunt J, Middleton S, LeBeau FE, Gillies MJ, Gillies MG, Davies CH, Maycox PR, Whittington MA, Racca C. Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2767-76. PMID 16525056 DOI: 10.1523/Jneurosci.5054-05.2006  0.481
2006 Gill CH, Brown JT, Shivji N, Lappin SC, Farmer C, Randall A, McNaughton NC, Cobb SR, Davies CH. Inhibition of Ih reduces epileptiform activity in rodent hippocampal slices. Synapse (New York, N.Y.). 59: 308-16. PMID 16421904 DOI: 10.1002/Syn.20242  0.757
2006 McNair K, Davies CH, Cobb SR. Plasticity-related regulation of the hippocampal proteome. The European Journal of Neuroscience. 23: 575-80. PMID 16420465 DOI: 10.1111/J.1460-9568.2005.04542.X  0.507
2005 Lappin SC, Dale TJ, Brown JT, Trezise DJ, Davies CH. Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons. Brain Research. 1065: 37-46. PMID 16336949 DOI: 10.1016/J.Brainres.2005.10.024  0.697
2005 Thuault SJ, Brown JT, Calver AR, Collingridge GL, Randall A, Davies CH. Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit. Epilepsy Research. 65: 41-51. PMID 15979855 DOI: 10.1016/J.Eplepsyres.2005.04.004  0.803
2005 Cobb SR, Davies CH. Cholinergic modulation of hippocampal cells and circuits. The Journal of Physiology. 562: 81-8. PMID 15528238 DOI: 10.1113/Jphysiol.2004.076539  0.478
2005 Brown JT, Richardson JC, Collingridge GL, Randall AD, Davies CH. Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. Hippocampus. 15: 110-7. PMID 15390159 DOI: 10.1002/Hipo.20036  0.835
2004 Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 46: 1168-1176. PMID 32585789 DOI: 10.1016/j.neuropharm.2004.02.014  0.311
2004 Thuault SJ, Brown JT, Sheardown SA, Jourdain S, Fairfax B, Spencer JP, Restituito S, Nation JH, Topps S, Medhurst AD, Randall AD, Couve A, Moss SJ, Collingridge GL, Pangalos MN, ... Davies CH, et al. The GABA(B2) subunit is critical for the trafficking and function of native GABA(B) receptors. Biochemical Pharmacology. 68: 1655-66. PMID 15451409 DOI: 10.1016/J.Bcp.2004.07.032  0.763
2004 Gill CH, Randall A, Bates SA, Hill K, Owen D, Larkman PM, Cairns W, Yusaf SP, Murdock PR, Strijbos PJ, Powell AJ, Benham CD, Davies CH. Characterization of the human HCN1 channel and its inhibition by capsazepine. British Journal of Pharmacology. 143: 411-21. PMID 15351778 DOI: 10.1038/Sj.Bjp.0705945  0.544
2004 Cunningham MO, Halliday DM, Davies CH, Traub RD, Buhl EH, Whittington MA. Coexistence of gamma and high-frequency oscillations in rat medial entorhinal cortex in vitro. The Journal of Physiology. 559: 347-53. PMID 15254156 DOI: 10.1113/Jphysiol.2004.068973  0.315
2004 McNaughton NC, Davies CH, Randall A. Inhibition of alpha(1E) Ca(2+) channels by carbonic anhydrase inhibitors. Journal of Pharmacological Sciences. 95: 240-7. PMID 15215649 DOI: 10.1254/Jphs.Fp0040032  0.495
2004 Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 46: 1168-76. PMID 15111023 DOI: 10.1016/J.Neuropharm.2004.02.014  0.424
2004 Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Luis Hannan S, Lappin SC, Egerton J, Smith GD, Worby A, Howett L, Owen D, Nasir S, Davies CH, et al. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology. 46: 133-49. PMID 14654105 DOI: 10.1016/S0028-3908(03)00305-8  0.609
2004 Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Hannan SL, Lappin SC, Egerton J, Smith GD, Worby A, Howett L, Owen D, Nasir S, Davies CH, et al. Erratum to “Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist” [Neuropharmacology 46 (2004) 133–149] Neuropharmacology. 46: 905. DOI: 10.1016/J.Neuropharm.2004.01.016  0.391
2003 Brown JT, Gill CH, Farmer CE, Lanneau C, Randall AD, Pangalos MN, Collingridge GL, Davies CH. Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices of GABAB1 receptor subunit knockout mice. Epilepsy Research. 57: 121-36. PMID 15013053 DOI: 10.1016/J.Eplepsyres.2003.10.013  0.851
2003 Harrison SM, Reavill C, Brown G, Brown JT, Cluderay JE, Crook B, Davies CH, Dawson LA, Grau E, Heidbreder C, Hemmati P, Hervieu G, Howarth A, Hughes ZA, Hunter AJ, et al. LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Molecular and Cellular Neurosciences. 24: 1170-9. PMID 14697676 DOI: 10.1016/J.Mcn.2003.09.001  0.663
2003 Cunningham MO, Davies CH, Buhl EH, Kopell N, Whittington MA. Gamma oscillations induced by kainate receptor activation in the entorhinal cortex in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9761-9. PMID 14586003 DOI: 10.1523/Jneurosci.23-30-09761.2003  0.407
2003 Charles KJ, Deuchars J, Davies CH, Pangalos MN. GABA B receptor subunit expression in glia. Molecular and Cellular Neurosciences. 24: 214-23. PMID 14550781 DOI: 10.1016/S1044-7431(03)00162-3  0.465
2003 Roshan-Milani S, Ferrigan L, Khoshnood MJ, Davies CH, Cobb SR. Regulation of epileptiform activity in hippocampus by nicotinic acetylcholine receptor activation. Epilepsy Research. 56: 51-65. PMID 14529953 DOI: 10.1016/J.Eplepsyres.2003.08.005  0.541
2003 van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. The Journal of Physiology. 549: 809-21. PMID 12702746 DOI: 10.1113/Jphysiol.2002.033290  0.352
2003 Cobb SR, Larkman PM, Bulters DO, Oliver L, Gill CH, Davies CH. Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region. Neuropharmacology. 44: 293-303. PMID 12604089 DOI: 10.1016/S0028-3908(02)00405-7  0.489
2002 Calver AR, Davies CH, Pangalos M. GABA(B) receptors: from monogamy to promiscuity. Neuro-Signals. 11: 299-314. PMID 12566919 DOI: 10.1159/000068257  0.355
2002 Gillies MJ, Traub RD, LeBeau FE, Davies CH, Gloveli T, Buhl EH, Whittington MA. A model of atropine-resistant theta oscillations in rat hippocampal area CA1. The Journal of Physiology. 543: 779-93. PMID 12231638 DOI: 10.1113/Jphysiol.2002.024588  0.449
2002 Thuault SJ, Davies CH, Randall AD, Collingridge GL. Group I mGluRs modulate the pattern of non-synaptic epileptiform activity in the hippocampus. Neuropharmacology. 43: 141-6. PMID 12213268 DOI: 10.1016/S0028-3908(02)00095-3  0.818
2002 Lanneau C, Harries MH, Ray AM, Cobb SR, Randall A, Davies CH. Complex interactions between mGluR1 and mGluR5 shape neuronal network activity in the rat hippocampus. Neuropharmacology. 43: 131-40. PMID 12213267 DOI: 10.1016/S0028-3908(02)00086-2  0.655
2002 Coumis U, Davies CH. The effects of galanin on long-term synaptic plasticity in the CA1 area of rodent hippocampus. Neuroscience. 112: 173-82. PMID 12044482 DOI: 10.1016/S0306-4522(02)00007-6  0.416
2002 Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology. 42: 127-33. PMID 11750922 DOI: 10.1016/S0028-3908(01)00156-3  0.436
2002 Gill CH, Soffin EM, Hagan JJ, Davies CH. 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology. 42: 82-92. PMID 11750918 DOI: 10.1016/S0028-3908(01)00149-6  0.472
2001 Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E, Charles KJ, Wood M, Davies CH, Pangalos MN. Gabapentin is not a GABAB receptor agonist. Neuropharmacology. 41: 965-75. PMID 11747901 DOI: 10.1016/S0028-3908(01)00140-X  0.722
2001 Kearns IR, Morton RA, Bulters DO, Davies CH. Opioid receptor regulation of muscarinic acetylcholine receptor-mediated synaptic responses in the hippocampus. Neuropharmacology. 41: 565-73. PMID 11587711 DOI: 10.1016/S0028-3908(01)00108-3  0.565
2001 Morton RA, Manuel NA, Bulters DO, Cobb SR, Davies CH. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by GABA(B) receptors in the rat hippocampus. The Journal of Physiology. 535: 757-66. PMID 11559773 DOI: 10.1111/J.1469-7793.2001.00757.X  0.541
2001 Davies B, Kearns IR, Ure J, Davies CH, Lathe R. Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 6993-7000. PMID 11549709 DOI: 10.1523/Jneurosci.21-18-06993.2001  0.43
2001 Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, Harries MH, Soffin E, Davies CH, Randall AD, Heightman T, Gaster L, Wyman P, Parker C, Price GW, et al. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue. British Journal of Pharmacology. 133: 797-806. PMID 11454652 DOI: 10.1038/Sj.Bjp.0704133  0.493
2001 Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, Smith D, Reynolds DS, Davies CH, Collingridge GL, Seabrook GR. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4691-8. PMID 11425896 DOI: 10.1523/Jneurosci.21-13-04691.2001  0.793
2001 Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Soffin EM, Farmer CE, Lanneau C, Gray J, Schenck E, Warmerdam BS, Clapham C, Reavill C, Rogers DC, ... ... Davies CH, et al. Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Molecular and Cellular Neurosciences. 17: 1059-70. PMID 11414794 DOI: 10.1006/Mcne.2001.0995  0.598
2000 O'Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, Bacon A, Allen SJ, Holmes F, Kahl U, Wang FH, Kearns IR, Ove-Ogren S, Dawbarn D, Mufson EJ, Davies C, et al. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proceedings of the National Academy of Sciences of the United States of America. 97: 11569-74. PMID 11016971 DOI: 10.1073/Pnas.210254597  0.332
2000 Cobb SR, Bulters DO, Davies CH. Coincident activation of mGluRs and mAChRs imposes theta frequency patterning on synchronised network activity in the hippocampal CA3 region. Neuropharmacology. 39: 1933-42. PMID 10963737 DOI: 10.1016/S0028-3908(00)00036-8  0.448
2000 Fitzjohn SM, Morton RA, Kuenzi F, Davies CH, Seabrook GR, Collingridge GL. Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices. Neuroscience Letters. 288: 9-12. PMID 10869803 DOI: 10.1016/S0304-3940(00)01204-0  0.792
1999 Cobb SR, Manuel NA, Morton RA, Gill CH, Collingridge GL, Davies CH. Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampus. Neuropharmacology. 38: 1723-32. PMID 10587088 DOI: 10.1016/S0028-3908(99)00158-6  0.765
1999 Cobb SR, Bulters DO, Suchak S, Riedel G, Morris RG, Davies CH. Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus. The Journal of Physiology. 518: 131-40. PMID 10373695 DOI: 10.1111/J.1469-7793.1999.0131R.X  0.44
1999 Pozza MF, Manuel NA, Steinmann M, Froestl W, Davies CH. Comparison of antagonist potencies at pre- and post-synaptic GABA(B) receptors at inhibitory synapses in the CA1 region of the rat hippocampus. British Journal of Pharmacology. 127: 211-9. PMID 10369475 DOI: 10.1038/Sj.Bjp.0702498  0.551
1999 Seabrook GR, Smith DW, Bowery BJ, Easter A, Reynolds T, Fitzjohn SM, Morton RA, Zheng H, Dawson GR, Sirinathsinghji DJ, Davies CH, Collingridge GL, Hill RG. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology. 38: 349-59. PMID 10219973 DOI: 10.1016/S0028-3908(98)00204-4  0.803
1998 Manuel NA, Davies CH. Pharmacological modulation of GABA(A) receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. British Journal of Pharmacology. 125: 1529-42. PMID 9884082 DOI: 10.1038/Sj.Bjp.0702237  0.499
1998 Steel M, Moss J, Clark KA, Kearns IR, Davies CH, Morris RG, Skarnes WC, Lathe R. Gene-trapping to identify and analyze genes expressed in the mouse hippocampus. Hippocampus. 8: 444-57. PMID 9825957 DOI: 10.1002/(Sici)1098-1063(1998)8:5<444::Aid-Hipo5>3.0.Co;2-X  0.452
1997 Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389: 599-603. PMID 9335499 DOI: 10.1038/39315  0.725
1997 Morton RA, Davies CH. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine receptors in the rat hippocampus. The Journal of Physiology. 502: 75-90. PMID 9234198 DOI: 10.1111/j.1469-7793.1997.075bl.x  0.47
1996 Davies CH, Collingridge GL. Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus. The Journal of Physiology. 496: 451-70. PMID 8910229 DOI: 10.1113/Jphysiol.1996.Sp021698  0.725
1995 Vignes M, Clarke VR, Davies CH, Chambers A, Jane DE, Watkins JC, Collingridge GL. Pharmacological evidence for an involvement of group II and group III mGluRs in the presynaptic regulation of excitatory synaptic responses in the CA1 region of rat hippocampal slices. Neuropharmacology. 34: 973-82. PMID 8532178 DOI: 10.1016/0028-3908(95)00093-L  0.675
1995 Davies CH, Clarke VR, Jane DE, Collingridge GL. Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones. British Journal of Pharmacology. 116: 1859-69. PMID 8528571 DOI: 10.1111/J.1476-5381.1995.Tb16674.X  0.705
1995 Bushell TJ, Jane DE, Tse HW, Watkins JC, Davies CH, Garthwaite J, Collingridge GL. Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4. Neuropharmacology. 34: 239-41. PMID 7617150 DOI: 10.1016/0028-3908(95)00012-U  0.767
1995 Bortolotto ZA, Bashir ZI, Davies CH, Taira T, Kaila K, Collingridge GL. Studies on the role of metabotropic glutamate receptors in long-term potentiation: some methodological considerations. Journal of Neuroscience Methods. 59: 19-24. PMID 7475246 DOI: 10.1016/0165-0270(94)00189-N  0.838
1995 Clark K, Davies C, Bashir Z, Bortolotto Z, Collingridge G. Roles of glutamate receptors in LTP in the hippocampus Pharmacological Research. 31: 153. DOI: 10.1016/1043-6618(95)86870-4  0.83
1994 Bortolotto ZA, Bashir ZI, Davies CH, Collingridge GL. A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation. Nature. 368: 740-3. PMID 8152485 DOI: 10.1038/368740A0  0.841
1994 Conquet F, Bashir ZI, Davies CH, Daniel H, Ferraguti F, Bordi F, Franz-Bacon K, Reggiani A, Matarese V, Condé F. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature. 372: 237-43. PMID 7969468 DOI: 10.1038/372237A0  0.714
1993 Bashir ZI, Bortolotto ZA, Davies CH, Berretta N, Irving AJ, Seal AJ, Henley JM, Jane DE, Watkins JC, Collingridge GL. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature. 363: 347-50. PMID 8388549 DOI: 10.1038/363347A0  0.841
1993 Davies CH, Pozza MF, Collingridge GL. CGP 55845A: a potent antagonist of GABAB receptors in the CA1 region of rat hippocampus. Neuropharmacology. 32: 1071-3. PMID 8295715 DOI: 10.1016/0028-3908(93)90073-C  0.726
1993 Davies CH, Collingridge GL. The physiological regulation of synaptic inhibition by GABAB autoreceptors in rat hippocampus. The Journal of Physiology. 472: 245-65. PMID 8145143 DOI: 10.1113/Jphysiol.1993.Sp019945  0.714
1992 Collingridge GL, Randall AD, Davies CH, Alford S. The synaptic activation of NMDA receptors and Ca2+ signalling in neurons. Ciba Foundation Symposium. 164: 162-71; discussion 1. PMID 1327677  0.837
1991 Davies CH, Starkey SJ, Pozza MF, Collingridge GL. GABA autoreceptors regulate the induction of LTP. Nature. 349: 609-11. PMID 1847993 DOI: 10.1038/349609A0  0.784
1990 Davies CH, Davies SN, Collingridge GL. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. The Journal of Physiology. 424: 513-31. PMID 2167975 DOI: 10.1113/Jphysiol.1990.Sp018080  0.639
1990 Davies CH, Collingridge GL. A method for studying physiological functions of presynaptic GABA(B) receptors in the rat hippocampal slice Journal of Physiology. 425: 24P.  0.688
1990 Randall AD, Schofield JG, Davies CH, Collingridge GL. The baclofen depression of excitatory synaptic transmission in rat hippocampus in vitro can be reversed by 2-hydroxy-saclofen Journal of Physiology. 426: 51P.  0.329
Low-probability matches (unlikely to be authored by this person)
2011 Barnes MR, Huxley-Jones J, Maycox PR, Lennon M, Thornber A, Kelly F, Bates S, Taylor A, Reid J, Jones N, Schroeder J, Scorer CA, Davies C, Hagan JJ, Kew JN, et al. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. Journal of Neuroscience Research. 89: 1218-27. PMID 21538462 DOI: 10.1002/Jnr.22647  0.281
2014 Rutter AR, Poffe A, Cavallini P, Davis TG, Schneck J, Negri M, Vicentini E, Montanari D, Arban R, Gray FA, Davies CH, Wren PB. GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species. The Journal of Pharmacology and Experimental Therapeutics. 350: 153-63. PMID 24784567 DOI: 10.1124/Jpet.114.214155  0.279
2012 Kew JNC, Davies CH. Cys loop receptors Ion Channels: From Structure to Function. DOI: 10.1093/acprof:oso/9780199296750.003.0007  0.275
2008 Roopun AK, Kramer MA, Carracedo LM, Kaiser M, Davies CH, Traub RD, Kopell NJ, Whittington MA. Temporal Interactions between Cortical Rhythms. Frontiers in Neuroscience. 2: 145-54. PMID 19225587 DOI: 10.3389/Neuro.01.034.2008  0.274
2008 Roopun AK, Kramer MA, Carracedo LM, Kaiser M, Davies CH, Traub RD, Kopell NJ, Whittington MA. Period concatenation underlies interactions between gamma and beta rhythms in neocortex. Frontiers in Cellular Neuroscience. 2: 1. PMID 18946516 DOI: 10.3389/Neuro.03.001.2008  0.269
2016 Mencacci NE, Kamsteeg EJ, Nakashima K, R'Bibo L, Lynch DS, Balint B, Willemsen MA, Adams ME, Wiethoff S, Suzuki K, Davies CH, Ng J, Meyer E, Veneziano L, Giunti P, et al. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions. American Journal of Human Genetics. 98: 763-71. PMID 27058447 DOI: 10.1016/J.Ajhg.2016.02.015  0.267
2019 Chan F, Lax NZ, Voss CM, Aldana BI, Whyte S, Jenkins A, Nicholson C, Nichols S, Tilley E, Powell Z, Waagepetersen HS, Davies CH, Turnbull DM, Cunningham MO. The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction. Brain : a Journal of Neurology. PMID 30689758 DOI: 10.1093/Brain/Awy320  0.265
2009 Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, Davies C, Hagan JJ, Scorer CA, Angelinetta C, Akbar MT, et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Molecular Psychiatry. 14: 1083-94. PMID 19255580 DOI: 10.1038/Mp.2009.18  0.264
2015 Chan F, Lax NZ, Davies CH, Turnbull DM, Cunningham MO. Neuronal oscillations: a physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases? Neuropharmacology. PMID 26518370 DOI: 10.1016/J.Neuropharm.2015.10.033  0.263
2012 Kew JNC, Davies CH. ATP receptors Ion Channels: From Structure to Function. DOI: 10.1093/acprof:oso/9780199296750.003.0009  0.25
2003 Ray AM, Benham CD, Roberts JC, Gill CH, Lanneau C, Gitterman DP, Harries M, Davis JB, Davies CH. Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10146-53. PMID 14602831  0.248
2015 Hirano K, Chen WS, Chueng AL, Dunne AA, Seredenina T, Filippova A, Ramachandran S, Bridges A, Chaudry L, Pettman G, Allan C, Duncan S, Lee KC, Lim J, Ma MT, ... ... Davies CH, et al. Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor. Antioxidants & Redox Signaling. PMID 26135714 DOI: 10.1089/Ars.2014.6202  0.238
2011 Whittington MA, Roopun AK, Traub RD, Davies CH. Circuits and brain rhythms in schizophrenia: a wealth of convergent targets. Current Opinion in Pharmacology. 11: 508-14. PMID 21555247 DOI: 10.1016/J.Coph.2011.04.010  0.232
2018 Gibbs KL, Kalmar B, Rhymes ER, Fellows AD, Ahmed M, Whiting P, Davies CH, Greensmith L, Schiavo G. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death & Disease. 9: 596. PMID 29789529 DOI: 10.1038/S41419-018-0624-8  0.229
2005 Southam E, Stratton SC, Davies CH. Anticonvulsant mechanisms for today and tomorrow. Drug News & Perspectives. 18: 483-7. PMID 16391717 DOI: 10.1358/Dnp.2005.18.8.944542  0.227
2023 Fradley R, Goetghebeur P, Miller D, Burley R, Almond S, Gruart I Massó A, Delgado García JM, Zhu B, Howley E, Neill JC, Grayson B, Gaskin P, Carlton M, Gray I, Serrats J, ... Davies CH, et al. Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia. Neurochemical Research. PMID 37289348 DOI: 10.1007/s11064-023-03956-2  0.219
2019 O'Donnell P, Rosen L, Alexander R, Murthy V, Davies CH, Ratti E. Strategies to address challenges in neuroscience drug discovery and development. The International Journal of Neuropsychopharmacology. PMID 31139821 DOI: 10.1093/Ijnp/Pyz027  0.217
2010 Griffiths SL, Salmon RL, Mason BW, Elliott C, Thomas DR, Davies C. Using the internet for rapid investigation of an outbreak of diarrhoeal illness in mountain bikers. Epidemiology and Infection. 138: 1704-11. PMID 20587125 DOI: 10.1017/S0950268810001561  0.195
2018 Salpietro V, Perez-Dueñas B, Nakashima K, San Antonio-Arce V, Manole A, Efthymiou S, Vandrovcova J, Bettencourt C, Mencacci NE, Klein C, Kelly MP, Davies CH, Kimura H, Macaya A, Houlden H. A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29392776 DOI: 10.1002/Mds.27286  0.194
2017 Little WT, Davies CH. Emerging strategies to treat the brain, behind its barrier. Neuropharmacology. PMID 28476641 DOI: 10.1016/J.Neuropharm.2017.04.044  0.192
2011 Trist DG, Davies CH. How technology can aid the pharmacologist in carrying out drug discovery. Current Opinion in Pharmacology. 11: 494-5. PMID 21704560 DOI: 10.1016/J.Coph.2011.06.001  0.176
1998 Money-Kyrle AR, Davies CH, Ranu HK, O'Gara P, Kent NS, Poole-Wilson PA, Harding SE. The role of cAMP in the frequency-dependent changes in contraction of guinea-pig cardiomyocytes. Cardiovascular Research. 37: 532-40. PMID 9614507 DOI: 10.1016/S0008-6363(97)00253-8  0.169
1994 Harding SE, Davies CH, Wynne DG, Poole-Wilson PA. Contractile function and response to agonists in myocytes from failing human heart. European Heart Journal. 15: 35-6. PMID 7713111 DOI: 10.1093/EURHEARTJ/15.SUPPL_D.35  0.169
2022 Evans R, Kimura H, Alexander R, Davies CH, Faessel H, Hartman DS, Ishikawa T, Ratti E, Shimizu K, Suzuki M, Tanaka S, Yukitake H, Dauvilliers Y, Mignot E. Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients. Proceedings of the National Academy of Sciences of the United States of America. 119: e2207531119. PMID 35994639 DOI: 10.1073/pnas.2207531119  0.165
1996 Davies CH, Ferrara N, Harding SE. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovascular Research. 31: 152-6. PMID 8849600 DOI: 10.1016/0008-6363(95)00187-5  0.126
1995 Harding SE, MacLeod KT, Davies CH, Wynne DG, Poole-Wilson PA. Abnormalities of the myocytes in ischaemic cardiomyopathy. European Heart Journal. 16: 74-81. PMID 8829961 DOI: 10.1093/Eurheartj/16.Suppl_I.74  0.118
1997 Davia K, Davies CH, Harding SE. Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle. Cardiovascular Research. 33: 88-97. PMID 9059532 DOI: 10.1016/S0008-6363(96)00187-3  0.108
1996 Harding SE, Brown LA, del Monte F, Davies CH, O'Gara P, Vescovo G, Wynne DG, Poole-Wilson PA. Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Research in Cardiology. 91: 53-6. PMID 8957545 DOI: 10.1007/BF00795363  0.075
2013 Barnes KB, Steward J, Thwaite JE, Lever MS, Davies CH, Armstrong SJ, Laws TR, Roughley N, Harding SV, Atkins TP, Simpson AJ, Atkins HS. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders. International Journal of Antimicrobial Agents. 41: 552-7. PMID 23517714 DOI: 10.1016/j.ijantimicag.2013.02.007  0.069
2012 Blin O, Davies CH, Lu B. Clinical innovation for neurodegenerative diseases Clinical Investigation. 2: 663-665. DOI: 10.4155/CLI.12.65  0.067
2010 Antonelli M, Asner DM, Bauer D, Becher T, Beneke M, Bevan AJ, Blanke M, Bloise C, Bona M, Bondar A, Bozzi C, Brod J, Buras AJ, Cabibbo N, Carbone A, ... ... Davies CH, et al. Flavor physics in the quark sector Physics Reports. 494. DOI: 10.1016/J.Physrep.2010.05.003  0.067
2023 Fradley R, Goetghebeur P, Miller D, Burley R, Almond S, Gruart I Massó A, Delgado García JM, Zhu B, Howley E, Neill JC, Grayson B, Gaskin P, Carlton M, Gray I, Serrats J, ... Davies CH, et al. Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia. Neurochemical Research. PMID 37440119 DOI: 10.1007/s11064-023-03987-9  0.066
2007 Wright G, Davies NA, Shawcross DL, Hodges SJ, Zwingmann C, Brooks HF, Mani AR, Harry D, Stadlbauer V, Zou Z, Zou Z, Williams R, Davies C, Moore KP, Jalan R. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology (Baltimore, Md.). 45: 1517-26. PMID 17523148 DOI: 10.1002/Hep.21599  0.066
2003 Zhu XX, Chow WH, Pan CY, Li GW, Shi HL, Tian H, Yang WY, Jiang J, Sun XC, Davies C. Addition of rosiglitazone to existing sulfonylurea treatment in Chinese patients with type 2 diabetes and exposure to hepatitis B or C Diabetes Technology and Therapeutics. 5: 33-42. PMID 12725705 DOI: 10.1089/152091503763816445  0.061
1998 Harding SE, Davies CH, Money-Kyrle AM, Poole-Wilson PA. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart. Cardiovascular Research. 40: 523-9. PMID 10070493 DOI: 10.1016/S0008-6363(98)00188-6  0.058
1996 Ravens U, Davia K, Davies CH, O'Gara P, Drake-Holland AJ, Hynd JW, Noble MI, Harding SE. Tachycardia-induced failure alters contractile properties of canine ventricular myocytes. Cardiovascular Research. 32: 613-21. PMID 8881522  0.057
2010 Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, Davies C, Hagan JJ, Scorer CA, Angelinetta C, Akbar T, et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function Molecular Psychiatry. 15: 442-443. DOI: 10.1038/mp.2009.148  0.055
2003 Li X, Jones M, Wang HF, Davies CH, Swanson JC, Hashimoto I, Rusk RA, Schindera ST, Barber BJ, Sahn DJ. Strain rate acceleration yields a better index for evaluating left ventricular contractile function as compared with tissue velocity acceleration during isovolumic contraction time: an in vivo study. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 16: 1211-6. PMID 14652598 DOI: 10.1067/J.Echo.2003.07.006  0.046
2000 Rusk RA, Mori Y, Davies CH, Irvine T, Kenny A, Sahn DJ. Comparison of ventricular volume and mass measurements from B- and C-scan images with the use of real-time 3-dimensional echocardiography: studies in an in vitro model. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 13: 910-7. PMID 11029715  0.044
2004 Hashimoto I, Bhat AH, Li X, Jones M, Davies CH, Swanson JC, Schindera ST, Sahn DJ. Tissue Doppler-derived myocardial acceleration for evaluation of left ventricular diastolic function. Journal of the American College of Cardiology. 44: 1459-66. PMID 15464328 DOI: 10.1016/J.Jacc.2004.06.067  0.042
2019 Hu T, Davies C. To What Extent did Monetary Policy Contribute Towards the Recent Financial Crisis and Subsequent Recession in the US and UK? International Research in Economics and Finance. 3: 9. DOI: 10.20849/iref.v3i2.691  0.037
2015 Treibel TA, Zemrak F, Sado DM, Banypersad SM, White SK, Maestrini V, Barison A, Patel V, Herrey AS, Davies C, Caulfield MJ, Petersen SE, Moon JC. Extracellular volume quantification in isolated hypertension - changes at the detectable limits? Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 17: 74. PMID 26264919 DOI: 10.1186/s12968-015-0176-3  0.036
2015 Cornes SP, Davies CH, Blyghton D, Sambrook MR, Beer PD. Contrasting anion recognition behaviour exhibited by halogen and hydrogen bonding rotaxane hosts. Organic & Biomolecular Chemistry. 13: 2582-7. PMID 25573517 DOI: 10.1039/C4Ob02547D  0.035
2001 Lodi R, Rajagopalan B, Blamire AM, Cooper JM, Davies CH, Bradley JL, Styles P, Schapira AH. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. Cardiovascular Research. 52: 111-9. PMID 11557239 DOI: 10.1016/S0008-6363(01)00357-1  0.034
2018 Asher A, Singhal A, Thornton G, Wragg A, Davies C. FFR derived from computed tomography angiography: the experience in the UK. Expert Review of Cardiovascular Therapy. 1-11. PMID 30347174 DOI: 10.1080/14779072.2018.1538786  0.034
1995 Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 92: 2540-9. PMID 7586355 DOI: 10.1161/01.CIR.92.9.2540  0.031
2021 Deighton AJ, Davies C, Bourantas C, Knight C, Woldman S, Deighton J, Azar A, Das D. Investigating consultant-led virtual review as a model for implementing 7-day cardiology services in UK clinical practice. Future Healthcare Journal. 8: e666-e670. PMID 34888462 DOI: 10.7861/fhj.2021-0115  0.031
2004 Conklin HM, Huang X, Davies CH, Sahn DJ, Shively BK. Biphasic left ventricular outflow and its mechanism in hypertrophic obstructive cardiomyopathy. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 17: 375-83. PMID 15044873 DOI: 10.1016/j.echo.2003.12.012  0.03
2012 Kew JNC, Davies CH. Ion Channels: From Structure to Function Ion Channels: From Structure to Function. 1-576. DOI: 10.1093/acprof:oso/9780199296750.001.0001  0.03
2021 Beirne AM, Rathod KS, Castle E, Andiapen M, Richards A, Bellin A, Hammond V, Godec T, Moon JC, Davies C, Bourantas CV, Wragg A, Ahluwalia A, Pugliese F, Mathur A, et al. The BYPASS-CTCA Study: the value of Computed Tomography Cardiac Angiography (CTCA) in improving patient-related outcomes in patients with previous bypass operation undergoing invasive coronary angiography: Study Protocol of a Randomised Controlled Trial. Annals of Translational Medicine. 9: 1395. PMID 34733947 DOI: 10.21037/atm-21-1455  0.029
2012 De'Ath HD, Vulliamy PE, Davies C, Uppal R. A large ventricular septal defect complicating resuscitation after blunt trauma. Journal of Emergencies, Trauma, and Shock. 5: 350-2. PMID 23248508 DOI: 10.4103/0974-2700.102409  0.029
1994 Harding SE, Brown LA, Wynne DG, Davies CH, Poole-Wilson PA. Mechanisms of beta adrenoceptor desensitisation in the failing human heart. Cardiovascular Research. 28: 1451-60. PMID 8001031 DOI: 10.1093/CVR/28.10.1451  0.027
2016 Choudhury T, Mozid A, Hamshere S, Yeo C, Pellaton C, Arnous S, Saunders N, Brookman P, Jain A, Locca D, Archbold A, Knight C, Wragg A, Davies C, Mills P, et al. An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. European Journal of Heart Failure. PMID 27790824 DOI: 10.1002/ejhf.676  0.027
2002 Leach L, Davies C. The modulation of endothelial cell permeability: winter meeting of the Anatomical Society of Great Britain and Ireland (ASGBI), London, UK, 2-4 January 2002. Journal of Anatomy. 200: 539-40. PMID 12162721 DOI: 10.1046/j.1469-7580.2002.00067.x  0.025
2018 Young WJ, Jeffery DA, Hua A, Primus C, Serafino Wani R, Das S, Wong K, Uppal R, Thomas M, Davies C, Lloyd G, Woldman S, Bhattacharyya S. Echocardiography in Patients With Infective Endocarditis and the Impact of Diagnostic Delays on Clinical Outcomes. The American Journal of Cardiology. PMID 29958712 DOI: 10.1016/j.amjcard.2018.04.039  0.025
2016 Vardhanabhuti V, Nicol E, Morgan-Hughes G, Roobottom CA, Roditi G, Hamilton MC, Bull RK, Pugliese F, Williams MC, Stirrup J, Padley S, Taylor A, Davies C, Bury R, Harden S. Recommendations for accurate CT diagnosis of suspected Acute Aortic Syndrome (AAS) - On behalf of the British Society of Cardiovascular Imaging (BSCI)/British Society of Cardiovascular CT (BSCCT). The British Journal of Radiology. 20150705. PMID 26916280 DOI: 10.1259/Bjr.20150705  0.025
2023 Jones DA, Beirne AM, Kelham M, Rathod KS, Andiapen M, Wynne L, Godec T, Forooghi N, Ramaseshan R, Moon JC, Davies C, Bourantas CV, Baumbach A, Manisty C, Wragg A, et al. Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial. Circulation. PMID 37772419 DOI: 10.1161/CIRCULATIONAHA.123.064465  0.024
2018 Martin N, Manoharan K, Thomas J, Davies C, Lumbers RT. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. The Cochrane Database of Systematic Reviews. 6: CD012721. PMID 29952095 DOI: 10.1002/14651858.CD012721.pub2  0.024
2006 Mayosi BM, Kardos A, Davies CH, Gumedze F, Hovnanian A, Burge S, Watkins H. Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure. Heart (British Cardiac Society). 92: 105-9. PMID 15845614 DOI: 10.1136/hrt.2004.051037  0.023
2021 Martin N, Manoharan K, Davies C, Lumbers RT. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. The Cochrane Database of Systematic Reviews. 5: CD012721. PMID 34022072 DOI: 10.1002/14651858.CD012721.pub3  0.023
2002 Mayosi BM, Keavney B, Kardos A, Davies CH, Ratcliffe PJ, Farrall M, Watkins H. Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass. European Heart Journal. 23: 1963-71. PMID 12473259 DOI: 10.1053/Euhj.2002.3288  0.023
2015 Ang R, Hunter RJ, Baker V, Richmond L, Dhinoja M, Sporton S, Schilling RJ, Pugliese F, Davies C, Earley M. Pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult pulmonary vein isolation and phrenic nerve injury during cryoballoon ablation for paroxysmal atrial fibrillation. International Journal of Cardiology. 195: 253-8. PMID 26048388 DOI: 10.1016/j.ijcard.2015.05.089  0.021
2020 Lau CWZ, Hamers AJP, Rathod KS, Shabbir A, Cooper J, Primus CP, Davies C, Mathur A, Moon JC, Kapil V, Ahluwalia A. Randomised, double-blind, placebo-controlled clinical trial investigating the effects of inorganic nitrate in hypertension-induced target organ damage: protocol of the NITRATE-TOD study in the UK. Bmj Open. 10: e034399. PMID 31969369 DOI: 10.1136/bmjopen-2019-034399  0.02
2015 Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N, Gulati A, Knight C, Locca D, Davies C, Cowie MR, Prasad S, Parmar M, et al. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. European Heart Journal. PMID 26333366 DOI: 10.1093/eurheartj/ehv390  0.019
1996 Davies CH, Harding SE, Poole-Wilson PA. Cellular mechanisms of contractile dysfunction in human heart failure. European Heart Journal. 17: 189-98. PMID 8732371 DOI: 10.1093/OXFORDJOURNALS.EURHEARTJ.A014834  0.019
2022 Sim DS, Jones DA, Davies C, Locca D, Veerapen J, Reid A, Godec T, Martin J, Mathur A. Cell administration routes for heart failure: a comparative re-evaluation of the REGENERATE-DCM and REGENERATE-IHD trials. Regenerative Medicine. 17: 891-903. PMID 36226504 DOI: 10.2217/rme-2022-0138  0.018
1998 Davies CH, Ormerod OJ. Failed coronary thrombolysis. Lancet. 351: 1191-6. PMID 9643708  0.017
2001 Xu J, Wu Y, Li X, Elsedfy G, Li J, Lee J, Davies CH, Sahn DJ. Accuracy of three-dimensional quantification of left ventricular function using magnetic sensor acquisition: a dynamic in vitro model. Chinese Medical Journal. 114: 1011-4. PMID 11677755  0.017
2011 Monney PA, Sekhri N, Burchell T, Knight C, Davies C, Deaner A, Sheaf M, Baithun S, Petersen S, Wragg A, Jain A, Westwood M, Mills P, Mathur A, Mohiddin SA. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart (British Cardiac Society). 97: 1312-8. PMID 21106555 DOI: 10.1136/Hrt.2010.204818  0.016
2002 Hashimoto I, Mori Y, Rusk RA, Davies CH, Li X, Mack GK, Sahn DJ. Strain rate imaging: an in vitro "validation" study using a physiologic balloon model mimicking the left ventricle. Echocardiography (Mount Kisco, N.Y.). 19: 669-77. PMID 12487636  0.016
2012 Dastidar AG, Pugliese F, Davies C, Westwood M, Timmis A, Wragg A, Petersen SE. Is there a role for stress CMR in stable chest pain with >60% predicted risk of coronary artery disease? Qjm : Monthly Journal of the Association of Physicians. 105: 1231. PMID 23132953 DOI: 10.1093/qjmed/hcs218  0.015
2001 Davies CH. Revascularization for cardiogenic shock. Qjm : Monthly Journal of the Association of Physicians. 94: 57-67. PMID 11181981  0.015
2002 Mayou RA, Thompson DR, Clements A, Davies CH, Goodwin SJ, Normington K, Hicks N, Price J. Guideline-based early rehabilitation after myocardial infarction. A pragmatic randomised controlled trial. Journal of Psychosomatic Research. 52: 89-95. PMID 11832254 DOI: 10.1016/S0022-3999(01)00300-2  0.014
2012 Kew JNC, Davies CH. Kir family Ion Channels: From Structure to Function. DOI: 10.1093/acprof:oso/9780199296750.003.0014  0.012
1999 Davies CH, Bashir Y. Beta-blockers for heart failure--time to think the unthinkable? Qjm : Monthly Journal of the Association of Physicians. 92: 673-8. PMID 10542308  0.011
2020 Young WJ, Hoare D, Bvekerwa I, Primus C, Wani RS, Das S, Wong K, Uppal R, Thomas M, Davies C, Lloyd G, Woldman S, Bhattacharyya S. Association of Vegetation Size With Valve Destruction, Embolism and Mortality. Heart, Lung & Circulation. PMID 33279409 DOI: 10.1016/j.hlc.2020.10.028  0.011
1989 Gunning RF, Davies CH. Isolation of Pasteurella haemolytica from teat lesions in ewes. The Veterinary Record. 125: 490. PMID 2595976  0.01
2020 Smith C, Freeman S, Heylings D, Davies C. Anatomy across the pond; how anatomy is taught and in how many hours in the United Kingdom. The Faseb Journal. 34: 1-1. DOI: 10.1096/fasebj.2020.34.s1.04079  0.01
2015 Yang KV, Lim CVS, Zhang K, Sun J, Yang X, Huang A, Wu X, Davies CH. Microstructure and Texture Evolution in Double-Cone Samples of Ti-6Al-4V Alloy with Colony Preform Microstructure Metallurgical and Materials Transactions a: Physical Metallurgy and Materials Science. DOI: 10.1007/s11661-015-3158-z  0.01
2013 Cobb SR, Davies CH. Neurodevelopmental disorders. Neuropharmacology. 68: 1. PMID 23402709 DOI: 10.1016/j.neuropharm.2013.02.001  0.01
2010 O'Glasser AY, Scott DL, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, Schwartz JM. Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation. Clinical Transplantation. 24: 643-51. PMID 19925473 DOI: 10.1111/j.1399-0012.2009.01136.x  0.01
2005 Pemberton J, Li X, Kenny A, Davies CH, Minette MS, Sahn DJ. Real-time 3-dimensional Doppler echocardiography for the assessment of stroke volume: an in vivo human study compared with standard 2-dimensional echocardiography. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 18: 1030-6. PMID 16198879 DOI: 10.1016/j.echo.2005.03.009  0.01
2003 Li X, Mack GK, Rusk RA, Dai XN, El-Sedfy GO, Davies CH, Sahn DJ. Will a handheld ultrasound scanner be applicable for screening for heart abnormalities in newborns and children? Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 16: 1007-14. PMID 14566291 DOI: 10.1016/S0894-7317(03)00489-9  0.01
2001 Li J, Li X, Mori Y, Rusk RA, Lee JS, Davies CH, Hashimoto I, El-Sedfy GO, Li XN, Sahn DJ. Quantification of flow volume with a new digital three-dimensional color Doppler flow approach: an in vitro study. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 20: 1303-11. PMID 11762542  0.01
1998 Harding SE, Davia K, Davies CH, del Monte F, Money-Kyrle AR, Poole-Wilson PA. From overload to failure: what happens inside the myocyte. Annals of Medicine. 30: 14-23. PMID 9800879  0.01
1998 Channon KM, Banning AP, Davies CH, Bashir Y. Coronary artery aneurysm rupture mimicking dissection of the thoracic aorta. International Journal of Cardiology. 65: 115-7. PMID 9699940  0.01
1997 Davies CH, Banning AP, Channon KM, Ormerod OJ. Coronary stenting of unprotected left main stem stenoses in elderly patients unsuitable for coronary surgery. International Journal of Cardiology. 62: 13-8. PMID 9363497  0.01
1995 Crowe MT, Davies CH, Gaines PA. Percutaneous management of superior vena cava occlusions. Cardiovascular and Interventional Radiology. 18: 367-72. PMID 8591622 DOI: 10.1007/BF00338303  0.01
1986 Davies CH, Stringer DA, Whyte H, Daneman A, Mancer K. Congenital hepatic fibrosis with saccular dilatation of intrahepatic bile ducts and infantile polycystic kidneys. Pediatric Radiology. 16: 302-5. PMID 3523408  0.01
Hide low-probability matches.